And leading the way with tomorrow's fuels today.
Iogen has been a leader in low-carbon fuels for more than 35 years. We were the first to use enzymatic hydrolysis technology to produce cellulosic ethanol on a commercial scale. In collaboration with Brazil's Raízen Energia, we built the world's largest and most successful cellulosic ethanol production facilities. And we were the first company to use RNG as a feedstock to make renewable hydrogen used to make fuels in refineries.
We've invested more than $500 million to develop and deploy our proprietary technology platform, and we've been awarded more than 300 patents along the way.
Today, iogen is one of the top five U.S.-registered producers of cellulosic biofuels and feedstocks—both of which are critical to the energy systems that will power our Net Zero world.
Iogen is focused on the science and technology that produces abundant, affordable RNG-based fuels while removing carbon from the atmosphere.
We are developing new ways to turn biomass into transportation fuels and using existing refinery infrastructure to do it.
It's all on our roadmap to Net Zero. Along with our partners and customers across industries and around the world, iogen is proving that eliminating carbon-intense fossil fuels can be accomplished one economically sound, low-risk step at a time.
President & CEO
Brian has led iogen's development of world-leading technology in the biofuels industry and forged alliances with major energy companies and investors, including Royal Dutch Shell and Goldman Sachs. He has also been active in the development of renewable fuels policy in the United States and has testified before both House and Senate committees.
He has received both the Raphael Katzen Award for distinguished contributions from the Society for Industrial Microbiology and Biotechnology and the Holmberg Award for Lifetime Achievement from the Advanced Bioeconomy Leadership Conference. He is recognized as one of the top 100 people in the Advanced Bioeconomy by Biofuels Digest.
Brian graduated from MIT with Bachelors degrees in Mechanical Engineering and Civil Engineering and a Masters degree in Mechanical Engineering. He has received 112 patents worldwide.
Pat has a broad range of experience in the development and commercialization of biofuels and biochemicals. He currently leads iogen's biogas business, leveraging the company's expertise in advanced biofuel markets and pioneering the company's utilization of biomethane in refineries to make renewable fuels.
He is a recognized expert on the dynamics of fuel credit markets and has spoken widely on the topic.
Pat was responsible for the development of iogen's enzyme business, which pioneered new products and applications in different industries around the world. (This business was acquired by Novozymes in 2013 for $80 million.)
He also led the design, construction, commissioning, and operations of the world's first cellulosic ethanol demonstration plant in Ottawa, Ontario and oversaw iogen's cellulosic biofuel project development activities.
Pat has a Bachelor of Civil Engineering and a Master of Construction Engineering and Management, from the University of Michigan. He has received 46 patents worldwide.
Lori leads our strategy and corporate development functions, including investment and M&A opportunities, government relations and policy strategy.
Before joining iogen in 2020, Lori was CAO and SVP Strategy and Corporate Development at Marsulex, an international clean-tech company with patented environmental technologies, and General Counsel at Birch Hill Equity Partners, focusing on M&A, fund formation, corporate governance and ESG, and sitting on investee boards including Marsulex. Previously, she practiced corporate and securities law with prominent Canadian law firms and leading US and Canadian businesses across a wide range of industries.
Lori has an MBA from the Richard Ivey School of Business, University of Western Ontario, an LL.B/JD from the University of Victoria and a BA (Econ) from the University of Calgary. She holds the Institute of Corporate Directors' ICD.D designation and has been named one of the 25 Most Influential Lawyers in Canada.
John has over 20 years of experience in commercialization, technology innovation, project development and environmental compliance. In 2021, John was promoted to VP Project Development and he is responsible for the development of our renewable natural gas production facilities in North America.
John joined iogen in 2004 and has held a number of roles of increasing responsibility, most recently as Senior Manager, Commercial Development where John has led or been a key resource in all of iogen's commercial project development efforts over the last 15 years.
John is a Professional Engineer and holds a Masters' Certificate in project Management from the Sprott School of Business in addition to a B.Eng. from Carleton University.
Claire has served as VP Finance with iogen since 2012 and she is responsible for all facets of the finance function including financial reporting, budgeting and forecasting, taxes and insurance, and played an integral role in commercializing the company's biogas business.
Claire began her career as a CPA with Deloitte LLP. She has extensive finance and accounting experience with both public and private companies and has previously worked at Cognos Inc, Boston Acoustics Inc. and Goodfellow Inc.
Claire holds a B.Comm from McGill University as well as a Diploma in Public Accountancy.
Vice President, Intellectual Property
Claire joined iogen in 2009 and she is responsible for the company's intellectual property strategy and patent portfolio. Prior to joining iogen, Claire managed all worldwide legal, patent and trademark work for Cytec Industries Inc., an international chemical and aerospace company with approximately $4 billion in revenue.
She began her career in private practice at a major New York City law firm, specializing in intellectual property litigation, counseling, and transaction work. Claire has a B.S. in Chemistry, and a J.D degree from Rutgers University, and is registered to practice before the United States Patent and Trademark Office.
There’s more to iogen.
Let’s connect for the future.